Recruiting
Phase 2

A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Sponsor:

Insmed Incorporated

Code:

NCT06013241

Conditions

Chronic Rhinosinusitis Without Nasal Polyps

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Brensocatib

Placebo

Mometasone furoate nasal spray (MFNS)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information